Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile — Trials · CancerIndex

Clinical trials

Registered studies

20 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04933617	Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas	terminated	Phase 1	8	National Cancer Institute (NCI)NIH	1	Jul 9, 2024	clinicaltrials
NCT05144347	Study of XL114 in Subjects With Non-Hodgkin's Lymphoma	terminated	Phase 1	2	ExelixisINDUSTRY	1	Jul 11, 2023	clinicaltrials